• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物及其衍生物作为 DNA 修复酶酪氨酰-DNA 磷酸二酯酶 1 的抑制剂。

Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.

机构信息

Novosibirsk Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia.

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia.

出版信息

Int J Mol Sci. 2023 Mar 17;24(6):5781. doi: 10.3390/ijms24065781.

DOI:10.3390/ijms24065781
PMID:36982848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10051138/
Abstract

Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an important repair enzyme that removes various covalent adducts from the 3' end of DNA. Particularly, covalent complexes of topoisomerase 1 (TOP1) with DNA stabilized by DNA damage or by various chemical agents are an examples of such adducts. Anticancer drugs such as the TOP1 poisons topotecan and irinotecan are responsible for the stabilization of these complexes. TDP1 neutralizes the effect of these anticancer drugs, eliminating the DNA adducts. Therefore, the inhibition of TDP1 can sensitize tumor cells to the action of TOP1 poisons. This review contains information about methods for determining the TDP1 activity, as well as describing the inhibitors of these enzyme derivatives of natural biologically active substances, such as aminoglycosides, nucleosides, polyphenolic compounds, and terpenoids. Data on the efficiency of combined inhibition of TOP1 and TDP1 in vitro and in vivo are presented.

摘要

酪氨酰-DNA 磷酸二酯酶 1(TDP1)是一种重要的修复酶,可从 DNA 的 3' 端去除各种共价加合物。特别是,拓扑异构酶 1(TOP1)与 DNA 的共价复合物通过 DNA 损伤或各种化学试剂稳定,是此类加合物的示例。拓扑异构酶 1 抑制剂如托泊替康和伊立替康等抗癌药物负责稳定这些复合物。TDP1 中和这些抗癌药物的作用,消除 DNA 加合物。因此,TDP1 的抑制可以使肿瘤细胞对 TOP1 抑制剂的作用敏感。本综述包含有关 TDP1 活性测定方法的信息,以及描述了天然生物活性物质的这些酶衍生物的抑制剂,如氨基糖苷类、核苷、多酚化合物和萜类化合物。还介绍了在体外和体内联合抑制 TOP1 和 TDP1 的效率的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/350ebc42f72d/ijms-24-05781-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/1c2569f15f65/ijms-24-05781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/2aee7c5662b9/ijms-24-05781-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f039fe9b61b7/ijms-24-05781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/d437d6cc077d/ijms-24-05781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/3e5ecbb50191/ijms-24-05781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f7687ca9a106/ijms-24-05781-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/7cce06c579d8/ijms-24-05781-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f31b7ee8c838/ijms-24-05781-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/5a19fe0167e3/ijms-24-05781-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/a4c3d4ae4232/ijms-24-05781-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/d83b47e60428/ijms-24-05781-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/3a1789ab1f06/ijms-24-05781-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/a25abd82885a/ijms-24-05781-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/5636f3df936b/ijms-24-05781-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/711ab700a9ac/ijms-24-05781-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/4e01ffe4d265/ijms-24-05781-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f75989bff1dc/ijms-24-05781-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/350ebc42f72d/ijms-24-05781-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/1c2569f15f65/ijms-24-05781-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/2aee7c5662b9/ijms-24-05781-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f039fe9b61b7/ijms-24-05781-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/d437d6cc077d/ijms-24-05781-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/3e5ecbb50191/ijms-24-05781-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f7687ca9a106/ijms-24-05781-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/7cce06c579d8/ijms-24-05781-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f31b7ee8c838/ijms-24-05781-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/5a19fe0167e3/ijms-24-05781-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/a4c3d4ae4232/ijms-24-05781-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/d83b47e60428/ijms-24-05781-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/3a1789ab1f06/ijms-24-05781-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/a25abd82885a/ijms-24-05781-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/5636f3df936b/ijms-24-05781-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/711ab700a9ac/ijms-24-05781-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/4e01ffe4d265/ijms-24-05781-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/f75989bff1dc/ijms-24-05781-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f0a/10051138/350ebc42f72d/ijms-24-05781-g018.jpg

相似文献

1
Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.天然产物及其衍生物作为 DNA 修复酶酪氨酰-DNA 磷酸二酯酶 1 的抑制剂。
Int J Mol Sci. 2023 Mar 17;24(6):5781. doi: 10.3390/ijms24065781.
2
Dual DNA topoisomerase 1 and tyrosyl-DNA phosphodiesterase 1 inhibition for improved anticancer activity.双重 DNA 拓扑异构酶 1 和酪氨酰-DNA 磷酸二酯酶 1 抑制提高抗癌活性。
Med Res Rev. 2019 Jul;39(4):1427-1441. doi: 10.1002/med.21587. Epub 2019 Apr 19.
3
Synthesis of Methoxy-, Methylenedioxy-, Hydroxy-, and Halo-Substituted Benzophenanthridinone Derivatives as DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) Inhibitors and Their Biological Activity for Drug-Resistant Cancer.甲氧基、亚甲二氧基、羟基和卤代取代苯并菲啶酮衍生物的合成作为 DNA 拓扑异构酶 IB(TOP1)和酪氨酰-DNA 磷酸二酯酶 1(TDP1)抑制剂及其对耐药性癌症的生物学活性。
J Med Chem. 2021 Jun 10;64(11):7617-7629. doi: 10.1021/acs.jmedchem.1c00318. Epub 2021 May 19.
4
Discovery, Synthesis, and Evaluation of Oxynitidine Derivatives as Dual Inhibitors of DNA Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1), and Potential Antitumor Agents.发现、合成及氧亚乙基啶衍生物作为 DNA 拓扑异构酶 IB(TOP1)和酪氨酰 DNA 磷酸二酯酶 1(TDP1)双重抑制剂及潜在抗肿瘤剂的评价。
J Med Chem. 2018 Nov 21;61(22):9908-9930. doi: 10.1021/acs.jmedchem.8b00639. Epub 2018 Oct 31.
5
Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy.酪氨酰-DNA磷酸二酯酶作为抗癌治疗的靶点。
Anticancer Agents Med Chem. 2008 May;8(4):381-9. doi: 10.2174/187152008784220357.
6
The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.疏水性嘌呤核苷-Tdp1 抑制剂增强拓扑替康在体外诱导的 DNA 损伤,并增强拓扑替康在体内的抗肿瘤作用。
Molecules. 2022 Dec 31;28(1):323. doi: 10.3390/molecules28010323.
7
TDP2 promotes repair of topoisomerase I-mediated DNA damage in the absence of TDP1.在缺乏TDP1的情况下,TDP2促进拓扑异构酶I介导的DNA损伤修复。
Nucleic Acids Res. 2012 Sep 1;40(17):8371-80. doi: 10.1093/nar/gks622. Epub 2012 Jun 26.
8
Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.酪氨酰-DNA磷酸二酯酶(Tdp1)参与拓扑异构酶II介导的DNA损伤修复。
Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):8953-8. doi: 10.1073/pnas.0603455103. Epub 2006 Jun 2.
9
Tyrosyl-DNA phosphodiesterase 2 (TDP2) repairs topoisomerase 1 DNA-protein crosslinks and 3'-blocking lesions in the absence of tyrosyl-DNA phosphodiesterase 1 (TDP1).酪氨酰 DNA 磷酸二酯酶 2(TDP2)在缺乏酪氨酰 DNA 磷酸二酯酶 1(TDP1)的情况下修复拓扑异构酶 1 DNA-蛋白质交联物和 3'-阻断损伤。
DNA Repair (Amst). 2020 Jul-Aug;91-92:102849. doi: 10.1016/j.dnarep.2020.102849. Epub 2020 May 17.
10
Synthesis and biological evaluation of indenoisoquinolines that inhibit both tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1).吲哚异喹啉类抑制剂的合成与生物评价,该抑制剂既能抑制酪氨酰-DNA 磷酸二酯酶 I(Tdp1),又能抑制拓扑异构酶 I(Top1)。
J Med Chem. 2013 Jan 10;56(1):182-200. doi: 10.1021/jm3014458. Epub 2012 Dec 21.

引用本文的文献

1
Potent β-lactam-based tyrosyl-DNA phosphodiesterase 1 inhibitors identified by a virtual screen.通过虚拟筛选鉴定出的强效基于β-内酰胺的酪氨酰-DNA磷酸二酯酶1抑制剂。
Sci Rep. 2025 Jul 21;15(1):26510. doi: 10.1038/s41598-025-12503-8.
2
Dietary and lifestyle interventions for the management of hereditary ataxias.用于遗传性共济失调管理的饮食和生活方式干预措施。
Front Nutr. 2025 Apr 24;12:1548821. doi: 10.3389/fnut.2025.1548821. eCollection 2025.
3
Application of a bivalent "click" approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1).

本文引用的文献

1
[Effect of Usnic Acid-Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Used as Monotherapy or in Combination with Olaparib on Transplanted Tumors In Vivo].[源自松萝酸的酪氨酰-DNA磷酸二酯酶1抑制剂作为单一疗法或与奥拉帕尼联合使用对体内移植瘤的作用]
Mol Biol (Mosk). 2023 Mar-Apr;57(2):220-231.
2
The Lipophilic Purine Nucleoside-Tdp1 Inhibitor-Enhances DNA Damage Induced by Topotecan In Vitro and Potentiates the Antitumor Effect of Topotecan In Vivo.疏水性嘌呤核苷-Tdp1 抑制剂增强拓扑替康在体外诱导的 DNA 损伤,并增强拓扑替康在体内的抗肿瘤作用。
Molecules. 2022 Dec 31;28(1):323. doi: 10.3390/molecules28010323.
3
Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.
一种用于靶向酪氨酰-DNA磷酸二酯酶1(TDP1)的双价“点击”方法的应用。
RSC Med Chem. 2025 Feb 21;16(5):1969-1985. doi: 10.1039/d4md00824c. eCollection 2025 May 22.
4
Targeted sulfur(VI) fluoride exchange-mediated covalent modification of a tyrosine residue in the catalytic pocket of tyrosyl-DNA phosphodiesterase 1.靶向硫(VI)氟化物交换介导的酪氨酰-DNA磷酸二酯酶1催化口袋中酪氨酸残基的共价修饰。
Commun Chem. 2024 Sep 16;7(1):208. doi: 10.1038/s42004-024-01298-w.
5
Enhancement of the Clastogenic Effects of Topotecan In Vivo by Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.酪氨酸-DNA 磷酸二酯酶 1 抑制剂增强拓扑替康的体内致裂效应。
Bull Exp Biol Med. 2024 May;177(1):30-34. doi: 10.1007/s10517-024-06125-9. Epub 2024 Jul 2.
6
Enhancement of the Antitumor and Antimetastatic Effect of Topotecan and Normalization of Blood Counts in Mice with Lewis Carcinoma by Tdp1 Inhibitors-New Usnic Acid Derivatives.Tdp1抑制剂 - 新型扁枝衣酸衍生物增强拓扑替康对Lewis癌小鼠的抗肿瘤和抗转移作用并使血细胞计数恢复正常
Int J Mol Sci. 2024 Jan 19;25(2):1210. doi: 10.3390/ijms25021210.
7
Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.胃肠胰神经内分泌癌肿瘤球体药物筛选揭示了对酪氨酰-DNA 磷酸二酯酶 1 抑制剂的易感性。
Surgery. 2024 Mar;175(3):605-612. doi: 10.1016/j.surg.2023.08.044. Epub 2023 Oct 31.
8
Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents.松萝酸衍生物抑制 DNA 修复酶酪氨酰-DNA 磷酸二酯酶 1 和 2,并作为潜在的抗癌剂。
Genes (Basel). 2023 Oct 12;14(10):1931. doi: 10.3390/genes14101931.
9
New 5-Hydroxycoumarin-Based Tyrosyl-DNA Phosphodiesterase I Inhibitors Sensitize Tumor Cell Line to Topotecan.基于新型 5-羟基香豆素的酪氨酰 DNA 磷酸二酯酶 I 抑制剂增敏肿瘤细胞系对拓扑替康的敏感性。
Int J Mol Sci. 2023 May 23;24(11):9155. doi: 10.3390/ijms24119155.
通过杂环连接子连接的金刚烷-单萜化合物增强拓扑替康的细胞毒性作用。
Molecules. 2022 May 24;27(11):3374. doi: 10.3390/molecules27113374.
4
In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions.立体异构型亲脂性核苷对人酪氨酸-DNA 磷酸二酯酶 1(Tdp1)抑制的体外和计算研究:糖立体化学在配体-酶相互作用中的作用。
Molecules. 2022 Apr 9;27(8):2433. doi: 10.3390/molecules27082433.
5
Pyranodipyran Derivatives with Tyrosyl DNA Phosphodiesterase 1 Inhibitory Activities and Fluorescent Properties from sp. EGF 15-0-3.来源于 sp. EGF 15-0-3 的具有酪氨酰 DNA 磷酸二酯酶 1 抑制活性和荧光性质的吡喃并二吡喃衍生物
Mar Drugs. 2022 Mar 17;20(3):211. doi: 10.3390/md20030211.
6
New Deoxycholic Acid Derived Tyrosyl-DNA Phosphodiesterase 1 Inhibitors Also Inhibit Tyrosyl-DNA Phosphodiesterase 2.新型去氧胆酸衍生酪氨酸-DNA 磷酸二酯酶 1 抑制剂也抑制酪氨酸-DNA 磷酸二酯酶 2。
Molecules. 2021 Dec 23;27(1):72. doi: 10.3390/molecules27010072.
7
New Hybrid Compounds Combining Fragments of Usnic Acid and Thioether Are Inhibitors of Human Enzymes TDP1, TDP2 and PARP1.新型杂合化合物将地衣酸和硫醚片段结合,是人类酶 TDP1、TDP2 和 PARP1 的抑制剂。
Int J Mol Sci. 2021 Oct 20;22(21):11336. doi: 10.3390/ijms222111336.
8
The influence of an enamine usnic acid derivative (a tyrosyl-DNA phosphodiesterase 1 inhibitor) on the therapeutic effect of topotecan against transplanted tumors in vivo.一种烯胺岩大戟酸衍生物(酪氨酰-DNA 磷酸二酯酶 1 抑制剂)对拓扑替康在体内移植瘤治疗效果的影响。
Clin Exp Metastasis. 2021 Oct;38(5):431-440. doi: 10.1007/s10585-021-10113-y. Epub 2021 Aug 9.
9
New Hybrid Compounds Combining Fragments of Usnic Acid and Monoterpenoids for Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibition.新型乌苏烷酸和单萜类化合物杂合化合物可有效抑制酪氨酰 DNA 磷酸二酯酶 1
Biomolecules. 2021 Jul 1;11(7):973. doi: 10.3390/biom11070973.
10
Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.基于金刚烷连接的单萜类化合物通过杂环片段的新型 Tdp1 抑制剂。
Molecules. 2021 May 24;26(11):3128. doi: 10.3390/molecules26113128.